AXIN2
From Wikipedia, the free encyclopedia
Axin 2 (conductin, axil)
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | AXIN2; AXIL; DKFZp781B0869; MGC126582 | |||||||||||||
External IDs | OMIM: 604025 MGI: 1270862 HomoloGene: 3420 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 8313 | 12006 | ||||||||||||
Ensembl | ENSG00000168646 | ENSMUSG00000000142 | ||||||||||||
Uniprot | Q9Y2T1 | Q3UQK5 | ||||||||||||
Refseq | NM_004655 (mRNA) NP_004646 (protein) |
XM_988944 (mRNA) XP_994038 (protein) |
||||||||||||
Location | Chr 17: 60.96 - 60.99 Mb | Chr 11: 108.74 - 108.77 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Axin 2 (conductin, axil), also known as AXIN2, is a human gene.[1]
The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair.[1]
[edit] References
[edit] Further reading
- Kikuchi A (2000). "Modulation of Wnt signaling by Axin and Axil.". Cytokine Growth Factor Rev. 10 (3-4): 255-65. PMID 10647780.
- Segditsas S, Tomlinson I (2007). "Colorectal cancer and genetic alterations in the Wnt pathway.". Oncogene 25 (57): 7531-7. doi: . PMID 17143297.
- Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791-806. PMID 8889548.
- Mai M, Qian C, Yokomizo A, et al. (1999). "Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24.". Genomics 55 (3): 341-4. doi: . PMID 10049590.
- von Kries JP, Winbeck G, Asbrand C, et al. (2000). "Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.". Nat. Struct. Biol. 7 (9): 800-7. doi: . PMID 10966653.
- Liu W, Dong X, Mai M, et al. (2000). "Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.". Nat. Genet. 26 (2): 146-7. doi: . PMID 11017067.
- Dong X, Seelan RS, Qian C, et al. (2001). "Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene.". Cytogenet. Cell Genet. 93 (1-2): 26-8. PMID 11474173.
- Leung JY, Kolligs FT, Wu R, et al. (2002). "Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.". J. Biol. Chem. 277 (24): 21657-65. doi: . PMID 11940574.
- Anderson CB, Neufeld KL, White RL (2002). "Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon.". Proc. Natl. Acad. Sci. U.S.A. 99 (13): 8683-8. doi: . PMID 12072559.
- Schwarz-Romond T, Asbrand C, Bakkers J, et al. (2002). "The ankyrin repeat protein Diversin recruits Casein kinase Iepsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling.". Genes Dev. 16 (16): 2073-84. doi: . PMID 12183362.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Lammi L, Arte S, Somer M, et al. (2004). "Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer.". Am. J. Hum. Genet. 74 (5): 1043-50. doi: . PMID 15042511.
- Kouzmenko AP, Takeyama K, Ito S, et al. (2004). "Wnt/beta-catenin and estrogen signaling converge in vivo.". J. Biol. Chem. 279 (39): 40255-8. doi: . PMID 15304487.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- Hughes TA, Brady HJ (2005). "Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNA.". J. Biol. Chem. 280 (9): 8581-8. doi: . PMID 15611123.
- Hughes TA, Brady HJ (2005). "E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation.". Biochem. Biophys. Res. Commun. 329 (4): 1267-74. doi: . PMID 15766563.
- Koinuma K, Yamashita Y, Liu W, et al. (2006). "Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability.". Oncogene 25 (1): 139-46. doi: . PMID 16247484.
- Liu W, Rui H, Wang J, et al. (2006). "Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia.". EMBO J. 25 (8): 1646-58. doi: . PMID 16601693.
- Lejeune S, Guillemot F, Triboulet JP, et al. (2006). "Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.". Hum. Mutat. 27 (10): 1064. doi: . PMID 16941501.